Hope on the Horizon: Clinical Trials for Ebola Treatments Begin in DR Congo Against Deadly Bundibugyo Strain

In a significant stride for global health, the Democratic Republic of Congo has commenced clinical trials for two potential Ebola treatments, MBP134 and remdesivir, targeting the virulent Bundibugyo strain under the watchful eye of the World Health Organization.

Loading lens…